Research Article

Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells

Figure 3

Proliferation of tumor cells in the presence of anti-EGFR mAbs. Proliferation of (a) A431, (b) Caco2, (c) HCT116, (d) HT29, and (e) RKO cells in the presence of different concentrations of the anti-EGFR mAbs cetuximab (black bars), zalutumumab (light grey bars), and panitumumab (dark grey bars). Concentrations were 30–10–5–2.5–1–0.5–0.1 μg/ml. Bars represent mean ± SEM. , compared to the lowest concentration.
(a)
(b)
(c)
(d)
(e)